Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma

BACKGROUND: Implementation of adjuvant therapies in non-metastatic melanoma improved treatment outcomes in some patients; however, adjuvant therapy can be associated with significant cost and risk of toxicity. Therefore, there is an unmet need to better identify patients at high risk of recurrence....

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, M.A., Polivka, J., Huang, H.J., Treskova, I., Pivovarcikova, K., Fikrle, T., Woznica, V., Dustin, D.J., Call, S.G., Meric-Bernstam, F., Pesta, M., Janku, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695283/
https://www.ncbi.nlm.nih.gov/pubmed/34942440
http://dx.doi.org/10.1016/j.esmoop.2021.100357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695283/
https://www.ncbi.nlm.nih.gov/pubmed/34942440
http://dx.doi.org/10.1016/j.esmoop.2021.100357

Ejemplares similares